These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29891201)

  • 41. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring: a potential role for parotid-sparing techniques?
    Chang DT; Amdur RJ; Pacholke H; Mendenhall NP; Morris CG; Byer GA; Olivier KR
    Am J Clin Oncol; 2009 Apr; 32(2):145-9. PubMed ID: 19307951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A density assignment method for dose monitoring in head-and-neck radiotherapy.
    Barateau A; Perichon N; Castelli J; Schick U; Henry O; Chajon E; Simon A; Lafond C; De Crevoisier R
    Strahlenther Onkol; 2019 Feb; 195(2):175-185. PubMed ID: 30302507
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    van Dijk LV; Noordzij W; Brouwer CL; Boellaard R; Burgerhof JGM; Langendijk JA; Sijtsema NM; Steenbakkers RJHM
    Radiother Oncol; 2018 Jan; 126(1):89-95. PubMed ID: 28951007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrasound GLCM texture analysis of radiation-induced parotid-gland injury in head-and-neck cancer radiotherapy: an in vivo study of late toxicity.
    Yang X; Tridandapani S; Beitler JJ; Yu DS; Yoshida EJ; Curran WJ; Liu T
    Med Phys; 2012 Sep; 39(9):5732-9. PubMed ID: 22957638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A quantitative assessment of volumetric and anatomic changes of the parotid gland during intensity-modulated radiotherapy for head and neck cancer using serial computed tomography.
    Ajani AA; Qureshi MM; Kovalchuk N; Orlina L; Sakai O; Truong MT
    Med Dosim; 2013; 38(3):238-42. PubMed ID: 23558146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early prediction of acute xerostomia during radiation therapy for nasopharyngeal cancer based on delta radiomics from CT images.
    Liu Y; Shi H; Huang S; Chen X; Zhou H; Chang H; Xia Y; Wang G; Yang X
    Quant Imaging Med Surg; 2019 Jul; 9(7):1288-1302. PubMed ID: 31448214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Density variation of parotid glands during IMRT for head-neck cancer: correlation with treatment and anatomical parameters.
    Fiorino C; Rizzo G; Scalco E; Broggi S; Belli ML; Dell'Oca I; Dinapoli N; Ricchetti F; Rodriguez AM; Di Muzio N; Calandrino R; Sanguineti G; Valentini V; Cattaneo GM
    Radiother Oncol; 2012 Aug; 104(2):224-9. PubMed ID: 22809587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.
    Li Y; Taylor JM; Ten Haken RK; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):660-9. PubMed ID: 17141973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of radiation-induced changes to parotid glands following conventional radiotherapy in patients with nasopharygneal carcinoma.
    Wu VW; Ying MT; Kwong DL
    Br J Radiol; 2011 Sep; 84(1005):843-9. PubMed ID: 21224300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose and volume impact on radiation-induced xerostomia.
    Marmiroli L; Salvi G; Caiazza A; Di Rienzo L; Massaccesi M; Murino P; Macchia G
    Rays; 2005; 30(2):145-8. PubMed ID: 16294907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial.
    Buettner F; Miah AB; Gulliford SL; Hall E; Harrington KJ; Webb S; Partridge M; Nutting CM
    Radiother Oncol; 2012 Apr; 103(1):82-7. PubMed ID: 22444242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy.
    Rudat V; Münter M; Rades D; Grötz KA; Bajrovic A; Haberkorn U; Brenner W; Debus J
    Radiother Oncol; 2008 Oct; 89(1):71-80. PubMed ID: 18707782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
    Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.
    Wendt TG; Abbasi-Senger N; Salz H; Pinquart I; Koscielny S; Przetak SM; Wiezorek T
    Radiat Oncol; 2006 Jun; 1():18. PubMed ID: 16790059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CT image biomarkers to improve patient-specific prediction of radiation-induced xerostomia and sticky saliva.
    van Dijk LV; Brouwer CL; van der Schaaf A; Burgerhof JGM; Beukinga RJ; Langendijk JA; Sijtsema NM; Steenbakkers RJHM
    Radiother Oncol; 2017 Feb; 122(2):185-191. PubMed ID: 27459902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction of Radiation-Induced Parotid Gland-Related Xerostomia in Patients With Head and Neck Cancer: Regeneration-Weighted Dose.
    van Rijn-Dekker MI; van Luijk P; Schuit E; van der Schaaf A; Langendijk JA; Steenbakkers RJHM
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):750-762. PubMed ID: 37150262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy.
    Amosson CM; Teh BS; Mai WY; Woo SY; Chiu JK; Donovan DT; Parke R; Carpenter LS; Lu HH; Grant WH; Butler EB
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):71-9. PubMed ID: 12577249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.